Key Releases are ad hoc announcements pursuant to SIX Swiss Exchange Article 53 Listing Rules.
News archive
News Archive Navigation
News Archive Navigation Language
February 2021
-
Featured NewsExpanding CAR-T manufacturing in Australia
Cell Therapies Pty Ltd has become the first approved CAR-T commercial manufacturing site in Australia, providing potentially faster access to CAR-T therapies to eligible patients in the region with life-threatening blood cancers.
Novartis global commercial CAR-T manufacturing footprint now spans four continents, bringing these transformative therapies closer to patients and healthcare professionals around the world. -
Featured NewsWorld Cancer Day 2021
We’re honoring World Cancer Day with a new series called “Let’s Talk About the C Word: From Cancer to Cures” to address challenging conversations on cancer.
January 2021
-
Featured NewsNovartis ranks second in 2021 Access to Medicine Index
Novartis maintained its position in the 2021 Access to Medicine Index, leading in its approach to product delivery, while performing strongly across all other areas of the Index.
-
Featured NewsNovartis 2020 Financial Results
Novartis announces the company’s fourth quarter and 2020 full year financial results.
December 2020
-
Featured NewsThe RUXCOVID clinical trial
The RUXCOVID clinical trial highlights the Novartis commitment to leverage our expertise and resources to support the global response to the COVID-19 pandemic.
-
Featured NewsThe Co-Creating Impact Summit for the society and the planet
The Co-Creating Impact Summit happening on December 9th, 2020, will gather experts inside and outside of Novartis to continue our work of improving our impact on the society and the planet.
-
Featured NewsWhy healthcare’s digital moment is now
Novartis Chief Digital Officer, Bertrand Bodson, and Microsoft Corporate Vice President Research & Incubation, Peter Lee, discussed why healthcare’s digital moment is now.
November 2020
-
Featured NewsMeet Novartis Management 2020Annual meeting highlights progress on the company’s transformation and growth strategy.
-
Featured NewsAchieving 100% renewable electricity
Five virtual power purchase agreements with three developers expected to add more than 275 megawatts of clean power to the electrical grid.
-
Featured NewsLeading performance in sustainability
Novartis included in Dow Jones Sustainability World Index, with industry-leading performance in environmental and social reporting and human capital.
-
Featured NewsStudy suggests there may be two stages of fatal lung disease in COVID-19
NIBR translational immunologists and academic colleagues observe two distinct molecular patterns of disease progression in lung tissue samples.
Pagination
- ‹ Previous page
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- …
- 11
- › Next page